definiens: shall mean the use of Immune Modulators solely for prophylactic and/or therapeutic treatment ofasthma, allergic rhinitis or COPD, administered via a Delivery Method . The Field specifically excludes, withoutlimitation : ( i ) the use of Immune Modulators for all other allergic indications, atopic indications, autoimmune disordersand / or inflammatory disorders ; and/or ( ii ) any administration of Immune Modulators other than via a Delivery Method;and / or ( iii ) any and all drug combinations incorporating any antigens ( including without limitation allergens ) for asthma, allergic rhinitis, COPD or for any other indication, whether the materials comprising such combinations areadministered simultaneously or separately at Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commissionpursuant to the Company ’s application requesting confidential treatment under Rule 406 of the Securities Act